TY - BOOK ID - 5373243 TI - Innovation in Pharmaceutical Biotechnology : Comparing National Innovation Systems at the Sectoral Level PY - 2006 SN - 1280606657 9786610606658 9264014047 9264014039 PB - Paris : OECD Publishing, DB - UniCat KW - Biomedical technology. KW - Biotechnology -- Research. KW - Biotechnology. KW - Pharmaceutical biotechnology -- Technological innovations. KW - Research. KW - Technology, Pharmaceutical. KW - Pharmaceutical biotechnology KW - Biotechnology KW - Biological Science Disciplines KW - Pharmacy KW - Technology KW - Investigative Techniques KW - Science KW - Health Occupations KW - Natural Science Disciplines KW - Technology, Industry, and Agriculture KW - Analytical, Diagnostic and Therapeutic Techniques and Equipment KW - Disciplines and Occupations KW - Technology, Industry, Agriculture KW - Biomedical Technology KW - Technology, Pharmaceutical KW - Research KW - Health & Biological Sciences KW - Pharmacy, Therapeutics, & Pharmacology KW - Technological innovations KW - Technological innovations. KW - Biopharmaceutical technology KW - Drugs KW - Pharmaceutical technology KW - Pharmaceutical biotechnology industry KW - Biotechnologie pharmaceutique KW - Industrie KW - Innovations UR - https://www.unicat.be/uniCat?func=search&query=sysid:5373243 AB - This publication examines the innovation system in pharmaceutical biotechnology in eight OECD countries - Belgium, Finland, France, Germany, Japan, the Netherlands, Norway and Spain. The report summarises the results of in-depth studies, providing a comparative analysis of participating countries' performance in science and innovation in biopharmaceuticals. It highlights specific characteristics of the national biopharmaceutical innovation systems in terms of their international openness and the specific role of demand-side factors in the innovation process. Major systemic failures affecting the functioning of the biopharmaceutical innovation systems are identified. Based on rich evidence, the report draws policy recommendations to foster innovation in biopharmaceuticals advocating an integrated policy approach. ER -